T. Rowe Price Associates
MPT

T. Rowe Price Associates’s Medical Properties Trust MPT Stock Holding History

T. Rowe Price Associates’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09M Buy
451,891
+34,986
+8% +$182K ﹤0.01% 1802
2025
Q4 		$2.08M Sell
416,905
-4,059
-1% -$21.1K ﹤0.01% 1731
2025
Q3 		$2.13M Buy
420,964
+26,729
+7% +$118K ﹤0.01% 1703
2025
Q2 		$1.7M Sell
394,235
-26,339
-6% -$130K ﹤0.01% 1709
2025
Q1 		$2.54M Buy
420,574
+17,037
+4% +$86.1K ﹤0.01% 1505
2024
Q4 		$1.59M Buy
403,537
+52,067
+15% +$233K ﹤0.01% 1756
2024
Q3 		$2.06M Buy
351,470
+15,358
+5% +$75.7K ﹤0.01% 1624
2024
Q2 		$1.45M Buy
336,112
+20,398
+6% +$97.7K ﹤0.01% 1719
2024
Q1 		$1.48M Sell
315,714
-55,190
-15% -$211K ﹤0.01% 1715
2023
Q4 		$1.82M Buy
370,904
+31,517
+9% +$154K ﹤0.01% 1579
2023
Q3 		$1.85M Buy
339,387
+12,749
+4% +$102K ﹤0.01% 1494
2023
Q2 		$3.02M Buy
326,638
+1,351
+0.4% +$11.4K ﹤0.01% 1339
2023
Q1 		$2.67M Buy
325,287
+45,412
+16% +$501K ﹤0.01% 1366
2022
Q4 		$3.12M Sell
279,875
-7,513
-3% -$87.3K ﹤0.01% 1304
2022
Q3 		$3.41M Buy
287,388
+97,465
+51% +$1.48M ﹤0.01% 1279
2022
Q2 		$2.9M Buy
189,923
+7,103
+4% +$128K ﹤0.01% 1519
2022
Q1 		$3.87M Buy
182,820
+16,131
+10% +$348K ﹤0.01% 1505
2021
Q4 		$3.94M Sell
166,689
-16,333
-9% -$350K ﹤0.01% 1529
2021
Q3 		$3.67M Sell
183,022
-401
-0.2% -$8.22K ﹤0.01% 1556
2021
Q2 		$3.69M Sell
183,423
-12,799
-7% -$274K ﹤0.01% 1573
2021
Q1 		$4.18M Buy
196,222
+27,389
+16% +$589K ﹤0.01% 1506
2020
Q4 		$3.68M Buy
168,833
+2,275
+1% +$44.3K ﹤0.01% 1486
2020
Q3 		$2.94M Sell
166,558
-14,110
-8% -$263K ﹤0.01% 1480
2020
Q2 		$3.4M Sell
180,668
-2,213
-1% -$39.2K ﹤0.01% 1436
2020
Q1 		$3.16M Buy
182,881
+20,214
+12% +$423K ﹤0.01% 1405
2019
Q4 		$3.43M Buy
162,667
+57,675
+55% +$1.17M ﹤0.01% 1471
2019
Q3 		$2.05M Buy
104,992
+5,617
+6% +$103K ﹤0.01% 1571
2019
Q2 		$1.73M Buy
99,375
+823
+0.8% +$14.8K ﹤0.01% 1636
2019
Q1 		$1.82M Buy
98,552
+1,104
+1% +$19.7K ﹤0.01% 1620
2018
Q4 		$1.57M Buy
97,448
+861
+0.9% +$13.6K ﹤0.01% 1635
2018
Q3 		$1.44M Buy
96,587
+1,006
+1% +$14.7K ﹤0.01% 1720
2018
Q2 		$1.34M Buy
95,581
+683
+0.7% +$9.05K ﹤0.01% 1716
2018
Q1 		$1.23M Buy
94,898
+855
+0.9% +$10.9K ﹤0.01% 1711
2017
Q4 		$1.3M Buy
94,043
+300
+0.3% +$4.05K ﹤0.01% 1699
2017
Q3 		$1.23M Hold
93,743
– – ﹤0.01% 1722
2017
Q2 		$1.21M Buy
93,743
+26
+0% +$346 ﹤0.01% 1712
2017
Q1 		$1.21M Buy
93,717
+11,721
+14% +$150K ﹤0.01% 1728
2016
Q4 		$1.01M Buy
81,996
+10,900
+15% +$141K ﹤0.01% 1778
2016
Q3 		$1.05M Sell
71,096
-44
-0.1% -$666 ﹤0.01% 1725
2016
Q2 		$1.08M Buy
71,140
+7,440
+12% +$105K ﹤0.01% 1683
2016
Q1 		$827K Buy
63,700
+22,000
+53% +$251K ﹤0.01% 1771
2015
Q4 		$480K Sell
41,700
-8,400
-17% -$95.9K ﹤0.01% 1982
2015
Q3 		$554K Hold
50,100
– – ﹤0.01% 1906
2015
Q2 		$657K Hold
50,100
– – ﹤0.01% 1888
2015
Q1 		$738K Buy
50,100
+5,100
+11% +$75.8K ﹤0.01% 1832
2014
Q4 		$620K Hold
45,000
– – ﹤0.01% 1866
2014
Q3 		$552K Hold
45,000
– – ﹤0.01% 1896
2014
Q2 		$596K Hold
45,000
– – ﹤0.01% 1876
2014
Q1 		$576K Hold
45,000
– – ﹤0.01% 1866
2013
Q4 		$550K Hold
45,000
– – ﹤0.01% 1858
2013
Q3 		$548K Buy
45,000
+9,400
+26% +$126K ﹤0.01% 1861
2013
Q2 		$510K Buy
+35,600
New +$561K ﹤0.01% 1854

Other funds holding MPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

T. Rowe Price Associates's MPT Position: Q1 2026 in Review

T. Rowe Price Associates increased its Medical Properties Trust (MPT) stake by 8.4% in Q1 2026, buying an estimated $182K and bringing the position to 451,891 shares worth $2.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1802.

T. Rowe Price Associates first reported a position in MPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.18M in Q1 2021. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • T. Rowe Price Associates held 451,891 shares of Medical Properties Trust worth $2.09M as of Q1 2026.
  • T. Rowe Price Associates bought 34,986 Medical Properties Trust shares in Q1 2026, an estimated $182K.
  • Medical Properties Trust made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1802 holding.
  • T. Rowe Price Associates first reported a position in Medical Properties Trust in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Medical Properties Trust position peaked at $4.18M in Q1 2021.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.